{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:20:44Z","timestamp":1789924844198,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd011611","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T00:00:00Z","timestamp":1443484800000}}],"reference-count":113,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011611.pub2","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T08:13:15Z","timestamp":1443514395000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults"],"prefix":"10.1002","author":[{"given":"Tayla L","family":"McCloud","sequence":"first","affiliation":[{"name":"University of Oxford; Department of Psychiatry; Warneford Hospital Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Caddy","sequence":"additional","affiliation":[{"name":"University of Oxford; Department of Psychiatry; Warneford Hospital Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"Jochim","sequence":"additional","affiliation":[{"name":"University of Oxford; Department of Psychiatry; Warneford Hospital Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M","family":"Rendell","sequence":"additional","affiliation":[{"name":"University of Oxford; Department of Psychiatry; Warneford Hospital Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R","family":"Diamond","sequence":"additional","affiliation":[{"name":"School of Public Health, Imperial College London; Neuroepidemiology and Ageing (NEA) Research Unit; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Shuttleworth","sequence":"additional","affiliation":[{"name":"University of Oxford; Department of Psychiatry; Warneford Hospital Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Brett","sequence":"additional","affiliation":[{"name":"University of Oxford; Department of Psychiatry; Warneford Hospital Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben H","family":"Amit","sequence":"additional","affiliation":[{"name":"Tel Aviv University; Department of Psychiatry, Sackler Faculty of Medicine; Tel Aviv Israel"},{"name":"Geha Mental Health Center; Research Unit; Petach Tiqva Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"McShane","sequence":"additional","affiliation":[{"name":"University of Oxford; Radcliffe Department of Medicine; John Radcliffe Hospital Level 4, Main Hospital, Room 4401C Oxford Oxfordshire UK OX3 9DU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layla","family":"Hamadi","sequence":"additional","affiliation":[{"name":"University of Oxford; Department of Psychiatry; Warneford Hospital Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Hawton","sequence":"additional","affiliation":[{"name":"Warneford Hospital; Centre for Suicide Research, University Department of Psychiatry; Oxford UK OX3 7JX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cipriani","sequence":"additional","affiliation":[{"name":"University of Oxford; Department of Psychiatry; Warneford Hospital Oxford UK"},{"name":"University of Verona; Department of Public Health and Community Medicine; Verona Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,9,29]]},"reference":[{"key":"10.1002\/14651858.CD011611.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1399-5618.2011.00971.x","article-title":"Early antidepressant effect of memantine during augmentation of lamotrigine inadequate response in bipolar depression: A double-blind, randomized, placebo-controlled trial","volume":"14","author":"Anand","year":"2012","journal-title":"Bipolar Disorders"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1038\/tp.2014.105","article-title":"Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression","volume":"4","author":"Lally","year":"2014","journal-title":"Translational Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/JCP.0000000000000109","article-title":"The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: A 12-week double-blind, randomized controlled trial","volume":"34","author":"Lee","year":"2014","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD011611.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/npp.2009.2","article-title":"Decreased glutamate\/glutamine levels may mediate cytidine's efficacy in treating bipolar depression: a longitudinal proton magnetic resonance spectroscopy study","volume":"34","author":"Yoon","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1038\/tp.2014.105","article-title":"Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression","volume":"4","author":"Lally","year":"2014","journal-title":"Translational Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: A randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD011611.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","article-title":"N-acetyl cysteine for depressive symptoms in bipolar disorder-a double-blind randomized placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biological Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD011611.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.euroneuro.2014.09.001","article-title":"Therapeutic effects of add-on low-dose dextromethorphan plus valproic acid in bipolar disorder","volume":"24","author":"Chen","year":"2014","journal-title":"European Neuropsychopharmacology"},{"issue":"33","key":"10.1002\/14651858.CD011611.pub2-BIB0010|cit10","first-page":"2309","article-title":"Acupunctura, \"vital\" drugs and psychopharmacological agents in the treatment of psychiatric patients with deep depressive disorders, with considerations on the probable neurophysiological mechanisms of the synergism of action [article in Italian]","volume":"68","author":"Cocchi","year":"1977","journal-title":"Minerva Medica"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0010-440X(61)80007-2","article-title":"The psychotropic effects of cycloserine: A new use for an antibiotic","volume":"2","author":"Crane","year":"1961","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0012|cit12","unstructured":"Dean O Berk M Cotton SM Bush AI Gama CS Kapczinski F N-acetyl cysteine (NAC) as an adjunctive therapy for bipolar depression conference poster P35 Bipolar disorders. Abstracts of the 9th International Conference on Bipolar Disorder; 2011 June 9-11; Pittsburgh [PA] 2011 38"},{"issue":"5","key":"10.1002\/14651858.CD011611.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1176\/ajp.135.5.562","article-title":"Dose-related biphasic effect of prolyl-leucyl-glycinamide (MIF-I) in depression","volume":"135","author":"Ehrensing","year":"1978","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0014|cit14","first-page":"127S","article-title":"Effects of ketamine versus scopolamine on individual depression and anxiety symptoms (abstract)","volume":"75","author":"Ellis","year":"2014","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jad.2012.01.024","article-title":"The DRD2\/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder","volume":"138","author":"Lee","year":"2012","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jad.2014.02.017","article-title":"Do the dissociative side effects of ketamine mediate its antidepressant effects?","volume":"159","author":"Luckenbaugh","year":"2014","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pnpbp.2011.11.011","article-title":"Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder","volume":"37","author":"Magalh\u00e3es","year":"2012","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0018|cit18","unstructured":"NCT01684163 Phase 2, double-blind, placebo controlled, randomized withdrawal, parallel efficacy and safety study of GLYX-13 in subjects with inadequate\/partial response to antidepressants during the current episode of major depressive disorder www.clinicaltrials.gov\/show\/NCT01684163"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0019|cit19","unstructured":"NCT01306760 The use of ketamine as an anaesthetic during electroconvulsive therapy (ECT) for depression: does it improve treatment outcome? www.clinicaltrials.gov\/show\/NCT01306760"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.psychres.2013.12.027","article-title":"A randomized comparison of ketamine versus methohexital anesthesia in electroconvulsive therapy","volume":"215","author":"Rasmussen","year":"2014","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0021|cit21","unstructured":"ACTRN12612000830897 A double blind, placebo controlled, randomised trial to evaluate the effect of mitochondrial agents, N-acetyl cysteine or placebo on the depressive phase of bipolar disorder www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12612000830897"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0022|cit22","unstructured":"ISRCTN14689382 Ketamine augmentation of ECT to improve outcomes in depression www.isrctn.org\/ISRCTN14689382"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0023|cit23","unstructured":"NCT01881763 Comparing therapeutic efficacy and cognitive side effects of electroconvulsive therapy (ECT) using ketamine versus methohexital anesthesia www.clinicaltrials.gov\/show\/NCT01881763"},{"issue":"7","key":"10.1002\/14651858.CD011611.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.biopsych.2012.05.003","article-title":"Ketamine for depression: where do we go from here?","volume":"72","author":"Aan Het Rot","year":"2012","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD011611.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00001756-200303030-00018","article-title":"Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study","volume":"14","author":"Abel","year":"2003","journal-title":"Neuroreport"},{"issue":"3","key":"10.1002\/14651858.CD011611.pub2-BIB0026|cit26","first-page":"63","article-title":"Safety and effectiveness of intranasal administration of sedative medications (ketamine, midazolam, or sufentanil) for urgent brief pediatric dental procedures","volume":"40","author":"Abrams","year":"1993","journal-title":"Anesthesia Progress"},{"issue":"2","key":"10.1002\/14651858.CD011611.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00213-013-3153-2","article-title":"Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR","volume":"230","author":"Akinfiresoye","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0924-977X(95)00033-L","article-title":"Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression","volume":"5 Suppl","author":"Altamura","year":"1995","journal-title":"Europen Neuropsychopharmacology"},{"issue":"7066","key":"10.1002\/14651858.CD011611.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD011611.pub2-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011612","article-title":"Ketamine and other glutamate receptor modulators for depression in adults","author":"Amit","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0031|cit31","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1980"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0032|cit32","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0033|cit33","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0034|cit34","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and Statistical Manual of Mental Disorders - Text Revision (DSM-IV-TR)","author":"American Psychiatric Association","year":"2000"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0035|cit35","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"3","key":"10.1002\/14651858.CD011611.pub2-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007954","article-title":"Antidepressants versus placebo for depression in primary care","author":"Arroll","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7454","key":"10.1002\/14651858.CD011611.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"7354","key":"10.1002\/14651858.CD011611.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"issue":"9","key":"10.1002\/14651858.CD011611.pub2-BIB0039|cit39","first-page":"1428-34","article-title":"What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?","volume":"67","author":"Bandelow","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpsychires.2014.04.017","article-title":"Inflammatory mediators of cognitive impairment in bipolar disorder","volume":"56","author":"Bauer","year":"2014","journal-title":"Journal of Psychiatric Research"},{"issue":"2","key":"10.1002\/14651858.CD011611.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"137-151","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nature Reviews. Neuroscience"},{"issue":"33","key":"10.1002\/14651858.CD011611.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1-56","DOI":"10.3310\/hta5330","article-title":"Subgroup analyses in randomized controlled trials: quantifying the risks of false-positives and false-negatives","volume":"5","author":"Brookes","year":"2001","journal-title":"Health Technology Assessment"},{"issue":"3","key":"10.1002\/14651858.CD011611.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jclinepi.2003.08.009","article-title":"Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test","volume":"57","author":"Brookes","year":"2004","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fphar.2013.00161","article-title":"Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants","volume":"4","author":"Browne","year":"2013","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD011611.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/2045125313507739","article-title":"Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy","volume":"4","author":"Caddy","year":"2014","journal-title":"Therapeutic Advances in Psychopharmacology"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0046|cit46","unstructured":"Caddy C Amit B McCloud T Rendell J Furukawa TA Hawton K Ketamine and other glutamate receptor modulators for depression in adults Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0047|cit47","unstructured":"Canadian Agency for Drugs and Technologies in Health Intravenous ketamine for the treatment of mental health disorders: a review of clinical effectiveness and guidelines http:\/\/www.cadth.ca\/en\/products\/rapid-response\/publication\/4759 (accessed Aug 2014)"},{"issue":"9665","key":"10.1002\/14651858.CD011611.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"746-58","DOI":"10.1016\/S0140-6736(09)60046-5","article-title":"Efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis","volume":"373","author":"Cipriani","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD011611.pub2-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006117.pub4","article-title":"Sertraline versus other antidepressive agents for depression","author":"Cipriani","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD011611.pub2-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006534.pub2","article-title":"Citalopram versus other anti-depressive agents for depression","author":"Cipriani","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"f3646","DOI":"10.1136\/bmj.f3646","article-title":"Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis","volume":"346","author":"Cipriani","year":"2013","journal-title":"BMJ"},{"issue":"10","key":"10.1002\/14651858.CD011611.pub2-BIB0052|cit52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006533.pub2","article-title":"Duloxetine versus other anti-depressive agents for depression","author":"Cipriani","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011611.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hup.2475","article-title":"The use of ketamine as an antidepressant: a systematic review and meta-analysis","volume":"30","author":"Coyle","year":"2015","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0054|cit54","first-page":"259","article-title":"Depression","volume-title":"Handbook of Assessment and Treatment Planning for Psychological Disorders","author":"Dozois","year":"2004"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0055|cit55","doi-asserted-by":"crossref","unstructured":"Dutta A McKie S Deakin JF Ketamine and other potential glutamate antidepressants Psychiatry Research 2015 1 13 10.1016\/j.psychres.2014.10.028","DOI":"10.1016\/j.psychres.2014.10.028"},{"issue":"7109","key":"10.1002\/14651858.CD011611.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"629-34","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"140-9","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving crossover trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"57-63","DOI":"10.1001\/archpsyc.1972.01750190059011","article-title":"Diagnostic criteria for use in psychiatric research","volume":"26","author":"Feighner","year":"1972","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"72-6","DOI":"10.1093\/ije\/31.1.72","article-title":"An empirical study of summary effect measures in meta-analyses","volume":"31","author":"Furukawa","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"49-52","DOI":"10.1097\/00004850-200501000-00010","article-title":"Imputing response rates from means and standard deviations in meta-analysis","volume":"20","author":"Furukawa","year":"2005","journal-title":"International Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"7-10","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD011611.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"468-70","DOI":"10.1001\/jama.297.5.468-b","article-title":"Association between unreported outcomes and effect size estimates in Cochrane meta-analyses","volume":"297","author":"Furukawa","year":"2007","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD011611.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"531-4","DOI":"10.1097\/JCP.0b013e31814f30b1","article-title":"Evidence-based guidelines for interpretation of the Hamilton Rating Scale for Depression","volume":"27","author":"Furukawa","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"9878","key":"10.1002\/14651858.CD011611.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","article-title":"Treatment of bipolar disorder","volume":"381","author":"Geddes","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0065|cit65","unstructured":"McMaster University (developed by Evidence Prime, Inc.) GRADEproGDT: GRADEpro Guideline Development Tool [www.guidelinedevelopment.org]"},{"issue":"12","key":"10.1002\/14651858.CD011611.pub2-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006815.pub2","article-title":"Hydroxyzine for generalised anxiety disorder","author":"Guaiana","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0067|cit67","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"issue":"7132","key":"10.1002\/14651858.CD011611.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"690-3","DOI":"10.1136\/bmj.316.7132.690","article-title":"Interpreting treatment effects in randomised trials","volume":"316","author":"Guyatt","year":"1998","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"7414","key":"10.1002\/14651858.CD011611.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"557-60","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0071|cit71","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0072|cit72","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0073|cit73","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0074|cit74","unstructured":"Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"43","key":"10.1002\/14651858.CD011611.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"Journal of Neuroscience"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"2037-44","DOI":"10.1038\/sj.npp.1300272","article-title":"Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory","volume":"28","author":"Honey","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD011611.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"425-7","DOI":"10.1097\/00004714-199612000-00003","article-title":"Induction of mania with serotonin reuptake inhibitors","volume":"16","author":"Howland","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD011611.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD011611.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archpsyc.60.3.261","article-title":"A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder","volume":"60","author":"Judd","year":"2003","journal-title":"Archives of General Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD011611.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1176\/appi.ajp.2012.12040531","article-title":"Synaptic mechanisms underlying rapid antidepressant action of ketamine","volume":"169","author":"Kavalali","year":"2012","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"g5673","DOI":"10.1136\/bmj.g5673","article-title":"Assessment and management of bipolar disorder: summary of updated NICE guidance","volume":"349","author":"Kendall","year":"2014","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1517\/14728222.9.1.153","article-title":"GABA and glutamate systems as therapeutic targets in depression and mood disorders","volume":"9","author":"Kendell","year":"2005","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"10","key":"10.1002\/14651858.CD011611.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"e76882","DOI":"10.1371\/journal.pone.0076882","article-title":"Characterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims database","volume":"8","author":"Kubitz","year":"2013","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1002\/14651858.CD011611.pub2-BIB0084|cit84","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004185.pub2","article-title":"Fluoxetine versus other types of pharmacotherapy for depression","author":"Magni","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011611.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/11599770-000000000-00000","article-title":"Ketamine for treatment-resistant unipolar depression: current evidence","volume":"26","author":"Mathew","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0086|cit86","doi-asserted-by":"crossref","unstructured":"McGirr A Berlim MT Bond DJ Fleck MP Yatham LN Lam RW A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes Psychological Medicine 2015 693 704","DOI":"10.1017\/S0033291714001603"},{"issue":"3","key":"10.1002\/14651858.CD011611.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey Initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"382-9","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1360-0443.2009.02761.x","article-title":"Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.","volume":"105","author":"Morgan","year":"2010","journal-title":"Addiction"},{"issue":"3","key":"10.1002\/14651858.CD011611.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"255-60","DOI":"10.1016\/S0165-0327(02)00120-9","article-title":"Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS)","volume":"77","author":"Muller","year":"2003","journal-title":"Journal of Affective Disorders"},{"issue":"9947","key":"10.1002\/14651858.CD011611.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(14)60844-8","article-title":"Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Murray","year":"2014","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jad.2013.11.014","article-title":"A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action","volume":"156","author":"Naughton","year":"2014","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-pharmtox-011613-135950","article-title":"Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds","volume":"54","author":"Niciu","year":"2014","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"2","key":"10.1002\/14651858.CD011611.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.biopsych.2008.09.029","article-title":"Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist","volume":"65","author":"Phelps","year":"2009","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD011611.pub2-BIB0096|cit96","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006531.pub2","article-title":"Paroxetine versus other anti-depressive agents for depression","author":"Purgato","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011611.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF03011442","article-title":"Ketamine: an update on the first twenty-five years of clinical experience","volume":"36","author":"Reich","year":"1989","journal-title":"Canadian Journal of Anaesthesia"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0098|cit98","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"11","key":"10.1002\/14651858.CD011611.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.4088\/JCP.09r05259gre","article-title":"The neurobiology of the switch process in bipolar disorder: a review","volume":"71","author":"Salvadore","year":"2010","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD011611.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"773-82","DOI":"10.1001\/archpsyc.1978.01770300115013","article-title":"Research diagnostic criteria: rationale and reliability","volume":"35","author":"Spitzer","year":"1978","journal-title":"Archives of General Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD011611.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1119-29","DOI":"10.1016\/S0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature","volume":"53","author":"Sterne","year":"2000","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD011611.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1051-63","DOI":"10.1017\/S0033291797005205","article-title":"Symptom profiles of depression among general medical service users compared with specialty mental health service users","volume":"27","author":"Suh","year":"1997","journal-title":"Psychological Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011611.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/acps.12343","article-title":"Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis","volume":"130","author":"Taylor","year":"2014","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD011611.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/09638230903469269","article-title":"Systematic review of lamotrigine augmentation of treatment resistant unipolar depression (TRD)","volume":"19","author":"Thomas","year":"2010","journal-title":"Journal of Mental Health"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0924-977X(96)00039-9","article-title":"Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)","volume":"7","author":"Vollenweider","year":"1997","journal-title":"European Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD011611.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12264-014-1484-6","article-title":"Rapid-onset antidepressant efficacy of glutamatergic system modulators: the neural plasticity hypothesis of depression","volume":"31","author":"Wang","year":"2015","journal-title":"Neuroscience Bulletin"},{"issue":"6","key":"10.1002\/14651858.CD011611.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"473-83","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0108|cit108","volume-title":"SF-12: How to Score the SF-12. Physical and Mental Health Summary Scales","author":"Ware","year":"1998"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0109|cit109","volume-title":"The ICD-10 Classification of Mental and Behavioural Disorders","author":"World Health Organization (WHO)","year":"1992"},{"issue":"12","key":"10.1002\/14651858.CD011611.pub2-BIB0110|cit110","first-page":"1569-85","article-title":"The World Health Organization quality of life assessment (WHOQOL): Development and general psychometric properties","volume":"46","author":"WHOQOL Group","year":"1998","journal-title":"Social Science and Medicine"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1192\/bjp.172.1.11","article-title":"Health of the nation outcome scales (HoNOS). Research and development","volume":"172","author":"Wing","year":"1998","journal-title":"British Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD011611.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD011611.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11126-012-9208-4","article-title":"Lamotrigine in the treatment of unipolar depression with and without comorbidities: a literature review","volume":"83","author":"Zavodnick","year":"2012","journal-title":"Psychiatric Quarterly"}],"updated-by":[{"DOI":"10.1002\/14651858.cd011611.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD011611.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:57:55Z","timestamp":1628535475000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD011611.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,29]]},"references-count":113,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011611.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,29]]}}}